Based on these findings further in vivo studies to elucidate the effect of these compounds on the complex pathways of DC regulation via IFN-γ and IL-4 as well as their effects on other T cell subsets such as T regulatory cells may lead to the development of clinical applications exploiting these compounds for the treatment of various immune diseases. The gene discussed is IL4; the disease is immune system disorder.